Cannabis Life Network

MAY 27, 2021

Early scientific research and clinical trials have shown promise in their ability to help supplement treatments for people with various neurological disorders with cannabidiol (CBD). CBD is a naturally occurring chemical compound found in cannabis, such as hemp.

Clinical Trials 76

Clinical Trials CBD Treatment Hemp 76

MMJ Recs

NOVEMBER 20, 2023

While there are over 100 different cannabinoids identified in cannabis, the two most well-known and widely studied are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). On the other hand, CBD is non-psychoactive and has gained attention for its potential therapeutic applications. Image by Pfüderi from Pixabay.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

The Cannigma

MARCH 7, 2022

So much attention is placed upon THC and CBD that sometimes the less abundant cannabinoids are forgotten about or not appreciated fully. These effects are shared by THC and CBD, but are typically less potent. However the combination of CBN and CBD produced longer-lasting results, supporting the entourage effect theory.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

CannaMD

AUGUST 8, 2020

In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. So sit back, relax – and if you can’t relax, grab some CBD! What is CBD? Let’s clear up one of the biggest sources of confusion right off the bat: CBD is a cannabis compound called cannabidiol.

CBD 100

CBD DEA Research and Development Hemp 100

Healer

DECEMBER 17, 2021

Studies have shown CBD to be a safe substance, but as with any new drug, you must make sure it doesn’t negatively interact with other medications. Numerous studies have shown that CBD is a safe, non-impairing, and non-habit-forming substance. Most often, CBD interacts with other drugs via liver metabolism. By Dr. Dustin Sulak.

CBD 98

CBD THC Conditions Medicine 98

Cannabis Law Report

JULY 27, 2021

and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Under the Leadership of Nicolas Schlienz, Ph.D., About Realm of Caring.

Data 81

Data Epilepsy Research and Development Clinical Trials 81

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. tetrahydrocannabinol (THC).

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Leafwell

MARCH 11, 2019

Cannabidiol (CBD) is still a big mystery in many ways.

Clinical Trials 68

Clinical Trials CBD Cannabinoids Chronic Pain 68

MMJ Recs

APRIL 1, 2024

In recent years, the spotlight on CBD (cannabidiol) within medical marijuana has intensified, with researchers and medical professionals delving deeper into its potential therapeutic benefits. CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

MGC Pharma

FEBRUARY 20, 2018

Cannabis is an effective tool for the treatment of topical skin conditions In a recent study by undertaken by MGC Pharma, our dermatologists found that CBD is effective in providing relief for relief for dry, red, flakey, oily and acne prone skin through CBD skincare.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

MedicalJane

OCTOBER 3, 2019

The United States Department of Defense and GW Pharmaceuticals are collaborating on a new clinical trial at the Montefiore Medical Center in New York. Dr. Eric Hollander, the Director of the Autism and Obsessive Compulsive Spectrum Program and Anxiety and Depression Program at Montefiore Hospital, is leading the clinical trial.

Clinical Trials 74

Clinical Trials Epilepsy Pharmaceutical Treatment 74

Cannabis Law Report

SEPTEMBER 9, 2021

MyMD to highlight its development pipeline for MYMD-1, an immunometabolic regulator, and Supera-CBD, a synthetic cannabidiol derivative. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, will present at the H.C. For more information, visit www.mymd.com.

Pharmaceutical 74

Pharmaceutical Clinical Trials Chronic Pain Epilepsy 74

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

The two active cannabinoids in marijuana are cannabidiol (CBD) and tetrahydrocannabinol (THC), the latter of which causes psychoactive effects while the former does not. CBD seems to help the body’s natural endocannabinoid system return to normalcy and function better. CBD for Anxiety.

Treatment 112

Treatment Conditions CBD Clinical Trials 112

Cannabis Law Report

AUGUST 19, 2021

Here we’re just talking about CBD. Cannabidiol or CBD, which is most commonly sold as oil at high street retailers, is one of the active ingredients of non-psychoactive cannabis. Cannabidiol or CBD, which is most commonly sold as oil at high street retailers, is one of the active ingredients of non-psychoactive cannabis.

Cannabinoids 105

Cannabinoids Seed-To-Sale Clinical Trials CBD 105

Puff Puff Post

OCTOBER 3, 2019

Previous success from treating epilepsy with Cannabinoids now motivates doctors to investigate the plant’s effectiveness in treating symptoms of autism. Epidiolex is a CBD-infused oral-based medication designed to help patients as young as two-years-old treat epilepsy disorders.

Research and Development 94

Research and Development Epilepsy Clinical Trials Treatment 94

LifeCannMD

FEBRUARY 27, 2024

The Science Behind Medical Marijuana and Its Effects on Epileptic Seizures Medical Marijuana has garnered significant attention for its benefits in treating epilepsy and seizures. CBD’s ability to reduce glutamate levels and enhance GABA activity can help to reduce seizures.

Clinical Trials 59

Clinical Trials Epilepsy Marijuana Research and Development 59

Medical Marijuana Program Connection

JANUARY 16, 2024

Share on PinterestCBD may not only help to reduce seizure-related symptoms in people with epilepsy, research shows. Rowena Naylor/Stocksy United Cannabidiol (CBD) has been approved for use in the treatment of two early-onset, intractable forms of epilepsy, Dravet syndrome and Lennox-Gastaut syndrome, since 2018. Read More

Clinical Trials 40

Clinical Trials CBD Epilepsy Treatment 40

MMJ Recs

DECEMBER 28, 2023

Strains with a balanced THC and CBD ratio are often recommended for their synergistic effects in pain relief without the intense psychoactive experience. CBD, a non-psychoactive cannabinoid, has gained attention for its anti-anxiety effects. Medical cannabis, with its anxiolytic properties, offers a potential solution.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Cannabis Law Report

SEPTEMBER 13, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. in the blood. For more information, visit www.mymd.com.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Therapy 40

Otherside Farms

JULY 25, 2019

CBD is the new craze you can now find it in makeup, oils, lotions, and even more but is it really worth all the hype? By now you’ve probably heard a co-worker, friend, or even family member tell you that they’ve been using CBD for some reason or another and now you’re trying to decide if you should try CBD out too.

Blood Pressure 12

Blood Pressure CBD Clinical Trials Epilepsy 12

Leafwell

MARCH 11, 2020

Cannabidiol (CBD) is still a big mystery in many ways. How it works and what effect it has on the body is not precisely known, partially because far more clinical trials need to take place before we can say anything for sure. Yes, we have studies, but many of them are animal or in vitro.

Clinical Trials 10

Clinical Trials CBD Cannabinoids Chronic Pain 10

TheAnswerPage

MARCH 11, 2022

In the clinical trials evaluating a purified CBD product (Epidiolex) in epilepsy patients, side effects including sedation, decreased appetite, diarrhea, sleep disturbance, infections, pneumonia, viral infections and weight loss were reported. ” Kirkland AE, Fadus MC et al. Psych Resear. 308 (2022).

Clinical Trials 40

Clinical Trials Epilepsy Events Sleep 40

Cannabis Law Report

AUGUST 21, 2019

The watchdog refused to allow its national health service to prescribe medical cannabis for children with severe epilepsy because there is “not enough evidence it works”, a decision which angered campaigners and parents who said their children will suffer as a result. The final guideline is expected to be published in November 2019.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Cannabis Law Report

AUGUST 24, 2021

The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. Based on a novel synthetic derivative of cannabidiol (CBD), Supera-CBD is being developed to address the rapidly growing CBD market, which includes both FDA approved drugs and CBD products not currently regulated as drugs.

Pharmaceutical 75

Pharmaceutical Clinical Trials Chronic Pain CBD 75

TheAnswerPage

FEBRUARY 8, 2022

Do individuals who abruptly stop taking CBD experience physical withdrawal symptoms? No, not according to a 2020 clinical trial which involved the abrupt withdrawal of CBD after four-weeks of use (750 mg twice daily taken orally). Abrupt withdrawal of cannabidiol (CBD): a randomized trial. Epilepsy Behav.

Clinical Trials 45

Clinical Trials Epilepsy CBD 45

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Puff Puff Post

DECEMBER 28, 2018

One recent observational study has shown an astonishing success rate of 80% in reducing negative behavioral patterns in test subjects by using CBD oil. We go deep into what this might mean for the future of therapy for Autism Spectrum Disorders (ASD), and how we might see the use of CBD oil for autism. CBD Oil For Autism: Highlights.

Treatment 76

Treatment Oil CBD Therapy 76

Cannabis Law Report

AUGUST 2, 2021

(OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

United Patients Group

JANUARY 8, 2023

Cannabis has also been used for centuries to treat gastrointestinal disorders, epilepsy, rheumatism and malaria. Many neurological conditions are associated with dysregulation of the ECS (for example: epilepsy, Parkinson’s disease). Ancient Chinese texts and Ayurvedic texts describe its use to treat inflammation, pain and spasms.

Blood Pressure 122

Blood Pressure Sleep Cannabinoids Clinical Trials 122

Otherside Farms

APRIL 14, 2020

Research on CBD ( cannabidiol ) shows that it has vast therapeutic properties. Some of the findings of different studies suggest that vaping CBD could have significant health benefits in treating and managing various health disorders. According to a study done in Brazil in 1973, CBD was found to block or lower convulsions in rodents.

CBD 52

CBD Research and Development Sleep Clinical Trials 52

The Joint Blog

JANUARY 31, 2021

According to a new study published in the Journal of Medical Case Reports , the daily use of high-CBD (cannabidiol) marijuana extracts is associated with improvements in the behavioral symptoms related to autism spectrum disorder (ASD). The individual was given very low-doses of marijuana extracts, no larger than 0.2 ml twice daily.

Epilepsy 62

Epilepsy Extraction Research and Development Clinical Trials 62

Cannabis Law Report

NOVEMBER 25, 2021

CBD is all the rage, and has been for quite some time. Most cannabis by-products are legal these days, and the CBD industry has been booming. Here are a few reasons why CBD products are more popular than ever this year. Epilepsy Treatment. However, hope in the form of CBD seems to be on the way.

CBD 52

CBD Clinical Trials Epilepsy Chronic Pain 52

Cannabis Law Report

JUNE 7, 2022

Cannabidiol or CBD is a compound derived from the Cannabis sativa plant, more prominently known as cannabis or hemp. On the contrary, researchers are leaning more towards CBD as a beneficial chemical with therapeutic effects on various physical and mental health problems, from anxiety to chronic pain. Potential Benefits of CBD.

Chronic Pain 52

Chronic Pain CBD Digestion Edibles 52

Cannabis Law Report

DECEMBER 28, 2021

This is all thanks to CBD, or cannabidiol, one of the most important cannabinoids identified in cannabis plants. But what makes CBD different from other cannabinoids is its therapeutic properties. So, no wonder CBD-related products are everywhere in the form of tinctures, gummies, oil, cosmetics, and a lot more.

CBD 52

CBD Clinical Trials Consumption Chronic Pain 52

TheAnswerPage

MAY 25, 2022

The results of recent clinical trials indicate that Cannabidiol (CBD) reduces seizures among patients with refractory epilepsies of various etiologies. Most of these clinical studies report efficacy over short time periods (. The long-term efficacy of cannabidiol in the treatment of refractory epilepsy.

Clinical Trials 40

Clinical Trials Epilepsy Treatment CBD 40

TheAnswerPage

JUNE 19, 2021

The results of recent clinical trials indicate that Cannabidiol (CBD) reduces seizures among patients with refractory epilepsies of various etiologies. Most of these clinical studies report efficacy over short time periods (. The long-term efficacy of cannabidiol in the treatment of refractory epilepsy.

Clinical Trials 40

Clinical Trials Epilepsy Treatment CBD 40

Green Relief

MAY 13, 2018

The benefits of CBD-rich cannabis concentrates for chronic traumatic encephalopathy (CTE) are well-known among football players and other pro athletes. government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”.

THC 64

THC CBD Cannabinoids Research and Development 64